Antimicrobial resistance research, funding and incentives – get updates next week in London at SMi event
Conference is taking place in London on 19 - 20 March. To join and be a part of the global force head on to Superbugs & Superdrugs website to book your attendance http://www.superbugssuperdrugs.com/ein
PROGRAMME HIGHLIGHTS:
Analyse the current status of antimicrobial resistance with industry led insight into current strategies to tackle AMR
• Jean-Pierre Paccaud, Director of Business Development at GARDP, Drugs for Neglected Diseases initiative (DNDi) - Day 1, 9:15
• Steve Holden, Medical Adviser, MSD - Day 1, 10:35
Hear exclusive case studies from a selection of pharmaceutical companies on clinical progress
• Conrad Lichtenstein, CSO, Nemesis bioscience - Day 1, 12:15
• David Brown, Managing Director and Founder, Alchemy Biomedical Consulting - Day 1, 12:55
• Learn about regulatory pathways for the registration of new antimicrobial agents:
• Mair Powell, Senior clinical assessor, MHRA - Day 2, 9:50
Evaluate the latest incentives and funding solutions to spur drug discovery:
• Mark Albrecht, Health Scientist, HHS/ASPR/BARDA - Day 1, 9:55
• Adrian Towse, Director, Office of Health Economics - Day 2, 10:30
Explore the latest novel alternatives to antibiotics currently in development:
• Cara Cassino, Chief Medical Officer, ContraFect - Day 2, 15:10
• Stephen Barat, Head of Pre-Clinical and Early Clinical Development, SCYNEXIS Inc - Day 2, 16:20
• Ian Henderson , Professor of Microbial Biology, University Of Birmingham - Day 2, 17:00
View the programme, speaker line-up, and book to attend at http://www.superbugssuperdrugs.com/ein
Superbugs & Superdrugs Team look forward to welcoming you next week to what is shaping up to be another successful show!
Contact:
+44 (0)20 7827 6000
events@smi-online.co.uk
STAY CONNECTED
LinkedIn – search 'SMi Pharma'
Twitter - @SMIpharm #smibugs
-------------------------------------------------------------------------------------------
Superbugs & Superdrugs Conference | 19 - 20 March 2018 | London, UK
http://www.superbugssuperdrugs.com/ein
-------------------------------------------------------------------------------------------
Luda Durneva
SMi Group
email us here
+44 (0)20 7827 6000
EIN Presswire does not exercise editorial control over third-party content provided, uploaded, published, or distributed by users of EIN Presswire. We are a distributor, not a publisher, of 3rd party content. Such content may contain the views, opinions, statements, offers, and other material of the respective users, suppliers, participants, or authors.